Benzinga | Jan 5, 2022 12:54PM EST

IBM Attempts To Divest Watson Health This Time For Over $1B

* International Business Machines Corp (NYSE:IBM) revived its sale process for IBM Watson Health, Axios reports.

* IBM looks to procure over $1 billion from the sale. IBM spent over $4 billion to build Watson Health via acquisitions.

* Watson Health now includes health care data and analytics business Truven Health Analytics, population health company Phytel, and medical imaging business Merge Healthcare.

* IBM first explored a sale of the division in early 2021.

* Price Action: IBM shares traded higher by 2.71% at $141.75 on the last check Wednesday.